3PC-12247-36220
2 vaccinations
12 coded responses
27 check-ins
12 free-text entries
8 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 395 / MS
- Registered
- 2021-08-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-06
Registered in v-safe
-
2021-08-06
Dose 1 — Moderna
-
2021-08-06
Survey response — day 0, dose 1MedDRA: Chest pain — Feeling: Fair · Site: Pain, Redness · Muscle or body achesFree text: chest pain 6 hours afterMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body achesAdult check-in
-
2021-08-08
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Mild chest painMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-09
- 2021-08-10
-
2021-08-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body achesAdult check-in
-
2021-08-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body achesAdult check-in
- 2021-08-13
-
2021-08-20
Survey response — day 14, dose 1MedDRA: Chest pain, Painful respiration — Feeling: FairFree text: Chest pain, left side. Worse with inhaling.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-27
Survey response — day 21, dose 1MedDRA: Headache, Oropharyngeal pain, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, headache, runny nose, sneezingMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-08
Survey response — day 28, dose 1MedDRA: Chest pain, Dyspnoea, Laboratory test abnormal, Loss of consciousness — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Passing out, shortness of breath, mild chest pain. Half of labs came back abnormal. Last checked 6 months ago and were fineMedDRA releases: 2024-11 · check-in free text available
-
2021-09-08
Report sent to call center — day 28, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-10
Dose 2 — Moderna
- 2021-09-10
-
2021-09-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-09-13
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Site: Pain · HeadacheFree text: Sore throat, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2021-09-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2021-09-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Abdominal pain · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-09-15
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-15
-
2021-09-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-09-16
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-17
Survey response — day 7, dose 2MedDRA: Heart rate increased — Feeling: Fair · Fatigue or tirednessFree text: Increased heart rateMedDRA releases: 2024-11 · check-in free text available
-
2021-09-17
Call successfulParticipant prefers to complete VAERS report online
-
2021-09-24
Survey response — day 14, dose 2MedDRA: Fatigue, Laboratory test abnormal — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: FatigueAbnormal labsMedDRA releases: 2024-11 · check-in free text available
-
2021-09-24
Report sent to call center — day 14, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-09-27
- 2021-10-01
- 2021-10-08
- 2021-10-17
-
2021-10-24
Survey response — day 42, dose 2MedDRA: Fatigue, Laboratory test abnormal — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fatigue Abnormal labsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-24
Report sent to call center — day 42, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-26
-
2021-12-10
Survey response — 3 months, dose 2MedDRA: Fatigue, Laboratory test abnormal — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Further abnormal labs. Extreme fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-13
-
2022-03-11
Survey response — 6 months, dose 2MedDRA: Antinuclear antibody positive, Autoimmune disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: positive ANA and other autoimmune symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-11
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-14
-
2022-09-12
Survey response — 12 months, dose 2MedDRA: Cough, Paraesthesia, Syncope — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Syncope Chronic cough Tingling in feetMedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-13
- 2022-09-13
- 2022-09-13
- 2022-09-13
- 2022-09-13
-
2022-09-17
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-17
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-06 | Moderna | No |
| 2 | 2021-09-10 | Moderna | No |
Call center
8 call center cases
3 successful · 5 unsuccessful
Free text
Release 9 — day 0, dose 1
Systemic reaction (other): chest pain 6 hours after
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Mild chest pain
Release 9 — day 14, dose 1
Symptoms: Chest pain, left side. Worse with inhaling.
Release 9 — day 21, dose 1
Symptoms: Sore throat, headache, runny nose, sneezing
Release 9 — day 28, dose 1
Symptoms: Passing out, shortness of breath, mild chest pain. Half of labs came back abnormal. Last checked 6 months ago and were fine
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Sore throat, runny nose
Release 9 — day 7, dose 2
Systemic reaction (other): Increased heart rate
Release 9 — day 14, dose 2
Symptoms: FatigueAbnormal labs
Release 10 — day 42, dose 2
Symptoms: Fatigue Abnormal labs
Release 10 — 3 months, dose 2
Symptoms: Further abnormal labs. Extreme fatigue
Release 11 — 6 months, dose 2
Symptoms: positive ANA and other autoimmune symptoms
Release 12 — 12 months, dose 2
Symptoms: Syncope Chronic cough Tingling in feet
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Antinuclear antibody positive | · | · | ✓ |
| SD | Autoimmune disorder | · | · | ✓ |
| SD | Chest pain | ✓ | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Loss of consciousness | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Painful respiration | ✓ | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
| SD | Syncope | · | · | ✓ |
| SRO | Chest pain | ✓ | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release